Clinical trial
Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification
NCT00032955 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification
- Lead sponsor
- University of California, Los Angeles
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2001
- Completion date
- August 31, 2002
- Enrollment
- 163
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.